세계의 경 카테터 심장 판막 치환술 - 시장 규모, 점유율, 성장 분석 : 제품별, 수술 접근법별, 최종 용도별, 용도별, 지역별 산업 예측(2024-2031년)
Transcatheter Heart Valve Replacement Market Size, Share, Growth Analysis, By Product, By Surgical Approach, By End-Use, By Application, By Region - Industry Forecast 2024-2031
상품코드:1619022
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 경 카테터 심장 판막 치환술 시장 규모는 2022년 58억 달러로 평가되었고, 2023년 66억 7,000만 달러에서 2031년에는 204억 달러로 성장해 예측기간 중(2024-2031년)의 CAGR은 15.0%로 성장할 전망입니다.
세계 경경 카테터 심장 판막 치환술(TAVR) 시장은 심각한 대동맥 판막 질환을 앓고있는 환자에게 전통적인 개심술을 대체하는 저 침습 수술로 선호되고 있으며 큰 성장을 이루고 있습니다. 치료법은 카테터 치료에 의한 인공 밸브의 이식을 가능하게 해, 수술 리스크, 입원 기간, 회복 시간을 최소한으로 억제하기 위해, 특히 리스크가 높은 환자나 수술 불가능한 환자에게 있어서 유익합니다. 진보, 환자층의 확대, 의료 제공업체 사이의 수용 확대 등이 있어, 고령자 인구 증가나 심혈관 질환의 급증에 의해 한층 더 박차가 걸려 있습니다. 개선 및 수술 결과 개선 을 보장하는 것을 목표로 하고 있습니다. 의료기기 제조업체와 헬스케어 이해관계자의 협력 관계가 강화됨에 따라, TAVR 시장은 지속적인 확대의 태세를 정돈해, 환자의 결과와 심혈관계의 상황을 크게 개선합니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차/1차 정보원
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
경 카테터 심장 판막 치환술 시장 규모 : 제품별, CAGR(2024-2031년)
시장 개요
경 카테터 폐동맥판 치환술
경 카테터 승모판 수리 및 교체
경 카테터 대동맥판 치환술
경 카테터 심장 판막 치환술 시장 규모 : 수술 접근법별, CAGR(2024-2031년)
시장 개요
경심 첨단 접근
경대퇴 접근
기타
경 카테터 심장 판막 치환술 시장 규모 : 최종 용도별, CAGR(2024-2031년)
시장 개요
카테터 실험실
병원
경 카테터 심장 판막 치환술 시장 규모 : 용도별, CAGR(2024-2031년)
시장 개요
폐동맥판질환
승모판 질환
대동맥판질환
경 카테터 심장 판막 치환술 시장 규모, CAGR(2024-2031년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비의 비교(2021-2023년)
주요 기업 프로파일
Edwards Lifesciences Corporation(USA)
Medtronic plc(Ireland)
Boston Scientific Corporation(USA)
Abbott Laboratories(USA)
JenaValve Technology, Inc.(USA)
SYMETIS(Switzerland)
Braile Biomedica(Brazil)
CryoLife, Inc.(USA)
Micro Interventional Devices, Inc.(USA)
LivaNova PLC(UK)
Meril Life Sciences Pvt. Ltd.(India)
Venus Medtech(Hangzhou) Inc.(China)
Suzhou Jiecheng Medical Technology Co. Ltd.(China)
Peijia Medical Limited(China)
Blue Sail Medical Co., Ltd.(China)
Colibri Heart Valve LLC(USA)
HighLife SAS(France)
Neovasc Inc.(Canada)
St. Jude Medical, Inc.(USA)
결론과 권장사항
JHS
영문 목차
영문목차
Global Transcatheter Heart Valve Replacement Market size was valued at USD 5.8 billion in 2022 and is poised to grow from USD 6.67 billion in 2023 to USD 20.4 billion by 2031, growing at a CAGR of 15.0% during the forecast period (2024-2031).
The global transcatheter heart valve replacement (TAVR) market is experiencing significant growth as it emerges as a preferred minimally invasive alternative to traditional open-heart surgery for patients suffering from severe aortic valve disease. This innovative procedure allows for the implantation of prosthetic valves through catheterization, minimizing surgical risks, hospital stays, and recovery times, making it particularly beneficial for high-risk or inoperable patients. Growth drivers include technological advancements, a larger patient demographic, and increased acceptance among healthcare providers, exacerbated by a growing aging population and a surge in cardiovascular conditions. Ongoing investment in research and development aims to enhance valve designs and imaging techniques, ensuring improved procedural outcomes. As collaborations between medical device manufacturers and healthcare stakeholders strengthen, the TAVR market is poised for sustained expansion, significantly improving patient outcomes and the cardiovascular landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Heart Valve Replacement market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Transcatheter Heart Valve Replacement Market Segmental Analysis
Global Transcatheter Heart Valve Replacement Market is segmented by product, surgical approach, end-use, application and region. Based on product, the market is segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement and transcatheter aortic valve replacement. Based on surgical approach, the market is segmented into transapical approach, transfemoral approach and others. Based on end-use, the market is segmented into cath labs and hospitals. Based on application, the market is segmented into pulmonary valvular heart disease, mitral valvular heart disease and aortic valvular heart disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Transcatheter Heart Valve Replacement Market
The Transcatheter Heart Valve Replacement (THVR) market is significantly influenced by the aging global population and the growing prevalence of heart disease. As individuals age, the incidence of heart valve diseases, particularly conditions like aortic stenosis, is on the rise, which in turn escalates the demand for THVR procedures. With longer life expectancies, more patients are likely to experience valve-related complications, resulting in an expanding market for innovative heart valve replacement solutions. This demographic trend, coupled with the increasing recognition of THVR's benefits over traditional surgical methods, is propelling the market forward, creating opportunities for advancements in medical technology and patient care.
Restraints in the Global Transcatheter Heart Valve Replacement Market
The Global Transcatheter Heart Valve Replacement (THVR) market faces several restraints, notably the high initial costs linked with the procedures. These expenses encompass not only the devices but also the required specialized equipment, making it a significant financial burden. Furthermore, reimbursement issues and inconsistent healthcare policies across various regions can create barriers that limit patient access to these advanced treatments. These financial and policy-related challenges may subsequently impede the overall growth and expansion of the market, as they affect both patient affordability and healthcare provider willingness to adopt THVR solutions in their practices.
Market Trends of the Global Transcatheter Heart Valve Replacement Market
The Global Transcatheter Heart Valve Replacement (THVR) market is experiencing significant growth, fueled by rapid technological advancements and an increasing preference for minimally invasive procedures. Cutting-edge innovations, including enhanced valve designs, state-of-the-art imaging techniques, and novel delivery systems, are revolutionizing the field, making procedures safer and more effective. This trend is not only reducing complications but also broadening the spectrum of patients eligible for treatment. Consequently, more healthcare providers are recognizing THVR as a preferred solution for aortic valve diseases, contributing to its expanded adoption and solidifying its position as a critical component of cardiac care worldwide.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Transcatheter Heart Valve Replacement Market Size by Product & CAGR (2024-2031)
Market Overview
Transcatheter Pulmonary Valve Replacement
Transcatheter Mitral Valve Repair & Replacement
Transcatheter Aortic Valve Replacement
Global Transcatheter Heart Valve Replacement Market Size by Surgical Approach & CAGR (2024-2031)
Market Overview
Transapical Approach
Transfemoral Approach
Others
Global Transcatheter Heart Valve Replacement Market Size by End-Use & CAGR (2024-2031)
Market Overview
Cath Labs
Hospitals
Global Transcatheter Heart Valve Replacement Market Size by Application & CAGR (2024-2031)
Market Overview
Pulmonary Valvular Heart Disease
Mitral Valvular Heart Disease
Aortic Valvular Heart Disease
Global Transcatheter Heart Valve Replacement Market Size & CAGR (2024-2031)
North America (Product, Surgical Approach, End-Use, Application)
US
Canada
Europe (Product, Surgical Approach, End-Use, Application)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Surgical Approach, End-Use, Application)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Surgical Approach, End-Use, Application)
Brazil
Rest of Latin America
Middle East & Africa (Product, Surgical Approach, End-Use, Application)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2021-2023)
Key Company Profiles
Edwards Lifesciences Corporation (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Medtronic plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Boston Scientific Corporation (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Abbott Laboratories (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
JenaValve Technology, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
SYMETIS (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Braile Biomedica (Brazil)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
CryoLife, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Micro Interventional Devices, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
LivaNova PLC (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Meril Life Sciences Pvt. Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Venus Medtech (Hangzhou) Inc. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Suzhou Jiecheng Medical Technology Co. Ltd. (China)
